FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines
For Immediate Release: April 30, 2019 The U.S. Food and Drug Administration today announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their …